NCT07060872View on ClinicalTrials.gov

the Effect of Formulation on Anxiety in Autist Childre A Randomized Controlled Trial Assesses Spirulina Syrup Plus Risperidone in Children With Non-idiopathic Autism. Anxiety is Measured Using the SCAS (Parent Version) Via Daily Online Surveys for One Week and Throughout a 3-month Follow-up Period.

NANot yet recruitingINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

July 7, 2025

Primary Completion Date

September 15, 2025

Study Completion Date

October 1, 2025

Conditions
Age 3 to 7 YearsMild Autism Spectrumno Other Illness or Disorder
Interventions
DIETARY_SUPPLEMENT

Spirulina Syrup

A natural dietary supplement derived from Spirulina algae, administered orally as a syrup formulation. Used as an adjunct therapy to assess its potential effect on reducing anxiety symptoms in children with non-idiopathic autism. Dosage and duration are standardized according to study protocol.

DIETARY_SUPPLEMENT

Placebo Syrup

Placebo Syrup

DRUG

Risperidone

Risperidone

Trial Locations (1)

8917634787

Sanaz Alamdar, Yazd

All Listed Sponsors
lead

Shahid Sadoughi University of Medical Sciences and Health Services

OTHER